The global vessel sealing devices market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2033, exhibiting a growth rate (CAGR) of 5.77% during 2025-2033. The market is propelled by rising prevalence of chronic diseases, technological advancements in surgical instruments, particularly in vessel sealing devices, and the increasing preference for minimally invasive surgeries.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024
|
USD 2.0 Billion |
Market Forecast in 2033
|
USD 3.5 Billion |
Market Growth Rate 2025-2033 | 5.77% |
Rising prevalence of chronic diseases
The rising frequency of chronic diseases like cancer, cardiovascular problems, and obesity is a major driver of the vessel sealing devices market growth. As these illnesses frequently require surgical procedures, there is an increased demand for sophisticated surgical equipment that can improve procedural efficacy and safety. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease including heart disease, cancer, diabetes, obesity, and hypertension. Besides, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Vessel sealing devices are especially important in procedures involving substantial tissue manipulation and hemostasis because they offer consistent sealing of blood vessels and tissue bundles, reducing intraoperative blood loss and postoperative problems. The growing burden of chronic diseases around the world, combined with the aging population, magnifies the need for surgical treatments, boosting the demand for effective vessel sealing solutions.
Increasing adoption of minimally invasive surgeries
Another key element creating a favorable vascular sealing devices market outlook is the transition to minimally invasive surgical (MIS) procedures. According to National Library of Medicine, in 2017, 9.8 million inpatient major operating room procedures were analyzed, of which 11.1% were MIS and 2.5% were robotic-assisted, compared with 9.6 million inpatient operating room procedures (11.2% MIS and 2.9% robotic-assisted) in 2018. Minimally invasive procedures, such as laparoscopic and robotic surgeries, have various advantages over traditional open surgeries, including less postoperative pain, shorter hospital stays, faster recovery times, and a lower chance of complications. Vessel sealing devices are essential for MIS procedures because they enable precise and successful hemostasis in limited surgical fields. The popularity of minimally invasive operations among patients and healthcare providers has led to increased demand for sophisticated vascular sealing technologies.
Rising healthcare expenditure
Increased healthcare spending and continued development of healthcare infrastructure worldwide are major drivers of the vessel sealing devices market. As per Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, in 2022, the insured share of the population reached 92% (a historic high). Private health insurance enrollment increased by 2.9 million individuals and Medicaid enrollment increased by 6.1 million individuals. Government and private sector expenditures in healthcare facilities, particularly in emerging nations, are leading to the construction of modern surgery centers outfitted with cutting-edge technology. This expansion improves the accessibility and affordability of advanced surgical procedures, increasing the use of vessel sealing devices. Furthermore, the focus on improving surgical results and patient safety in both developed and developing nations encourages the demand for high-performance surgical equipment, particularly vascular sealing devices.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Instruments accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product. This includes generators, instruments, and accessories. According to the report, instruments represented the largest segment.
Vessel sealing instruments are utilized in many different surgical procedures, including general surgery, gynecology, urology, and cardiovascular surgery. Their ability to produce consistent hemostasis and prevent intraoperative blood loss makes them essential in many complex and minimally invasive operations. The adaptability of these devices in handling diverse tissue kinds and sizes, as well as their compatibility with various surgical procedures, broadens their use range. Hence, the increasing number of surgeries is escalating the demand for vessel sealing devices, resulting in a considerable market share. As per data published by National Library of Medicine in 2020, a total of 4642 surgeries were performed per year in India for a population of 88,273. Cataract (22.8%), caesareans (3.8%), surgeries for fractures (3.27%) and hernia (2.86%) were the most common surgeries. Moreover, 44.2% of surgeries belonged to essential surgeries.
Breakup by Application:
Laparoscopic surgery holds the largest share of the industry
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes general surgery and laparoscopic surgery. According to the report, laparoscopic surgery accounted for the largest market share.
Advanced vascular sealing technologies considerably improve the precision and safety of laparoscopic surgery. These technologies enable surgeons to properly and swiftly seal blood arteries and tissue bundles, lowering blood loss and the risk of complications. The exact control over sealing and cutting decreases temperature diffusion to adjacent tissues, which is especially critical in the delicate and limited regions of laparoscopic surgery. This high level of precision drives the widespread adoption of vessel sealing devices in laparoscopic procedures. Besides, technological developments in both laparoscopic equipment and vascular sealing technologies have increased their popularity. Innovative features including integrated cutting and sealing capabilities, ergonomic designs, and improved energy delivery systems have considerably improved the effectiveness of vessel sealing devices.
Breakup by End User:
Hospitals and specialty clinics represent the leading market segment
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals and specialty clinics and ambulatory surgical centers. According to the report, hospitals and specialty clinics represented the largest segment.
The rise in chronic diseases is a crucial factor driving the growth of hospitals and specialty clinics. As per Centers of Diseases Control and Prevention, an estimated 129 million people in the US have at least 1 major chronic disease such as heart disease, cancer, diabetes, obesity, hypertension. Moreover, five of the top 10 leading causes of death in the US are, or are strongly associated with, preventable and treatable chronic diseases. Over the past 2 decades prevalence has increased steadily, and this trend is expected to continue. Chronic conditions such as diabetes, hypertension, cancer, and respiratory diseases require ongoing medical attention, frequent monitoring, and specialized treatments. This has led to a surge in demand for healthcare services and facilities that can manage these conditions effectively. Specialty clinics focusing on diabetes care, oncology, cardiology, and pulmonology are expanding to meet the needs of patients with chronic diseases which in turn is escalating the vessel sealing devices demand.
Breakup by Region:
North America leads the market, accounting for the largest vessel sealing devices market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest regional market for vessel sealing devices.
North America, especially he United States, has one of the most advanced healthcare systems in the world. The 2021 World Index on Healthcare Innovation, conducted by the Foundation for Research on Equal Opportunity (FREOPP), ranked the United States in 6th place among the world’s healthcare systems. The analysis finds that the United States is a global leader in scientific advancement but that our healthcare system is fiscally unsustainable. The availability of well-equipped hospitals, specialist surgical facilities, and clinics promotes the use of innovative medical technologies, such as vascular sealing devices. Besides, the region's healthcare system invests heavily in cutting-edge equipment and technology, allowing for high-quality surgical care. Moreover, the high healthcare spending, led by both the public and private sectors, enables significant investment in medical technologies and surgical innovations.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Generators, Instruments, Accessories |
Applications Covered | General Surgery, Laparoscopic Surgery |
End Users Covered | Hospitals and Specialty Clinics, Ambulatory Surgical Centers |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | B. Braun Melsungen AG, BOWA-electronic GmbH & Co. KG, Erbe Elektromedizin GmbH, Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, KLS Martin Group, Lamidey Noury Medical, Medtronic plc, Olympus Corporation, OmniGuide Holdings Inc., Xcellance Medical Technologies Private Limited, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The global vessel sealing devices market was valued at USD 2.0 Billion in 2024.
We expect the global vessel sealing devices market to exhibit a CAGR of 5.77% during 2025-2033.
The rising demand for safe and effective instruments, such as vessel sealing devices, during surgeries to reduce infection rates and blood loss, as they are easy to use, require less operational time, assist in reducing blood loss, etc., is primarily driving the global vessel sealing devices market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective gynecological, urological, cardiovascular, and orthopedic surgical procedures to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for vessel sealing devices.
Based on the product, the global vessel sealing devices market can be bifurcated into generators, instruments, and accessories. Currently, instruments hold the majority of the total market share.
Based on the application, the global vessel sealing devices market has been segmented into general surgery and laparoscopic surgery, where laparoscopic surgery currently exhibits a clear dominance in the market.
Based on the end user, the global vessel sealing devices market can be divided into hospitals and specialty clinics and ambulatory surgical centers. Currently, hospitals and specialty clinics account for the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global vessel sealing devices market include B. Braun Melsungen AG, BOWA-electronic GmbH & Co. KG, Erbe Elektromedizin GmbH, Hologic Inc., Intuitive Surgical Inc., Johnson & Johnson, KLS Martin Group, Lamidey Noury Medical, Medtronic plc, Olympus Corporation, OmniGuide Holdings Inc., and Xcellance Medical Technologies Private Limited.